| dc.contributor.author | Kılıçarslan, Oğuzhan | |
| dc.contributor.author | Yılmaz Çebi, Aslıhan | |
| dc.contributor.author | Uçar, Didar | |
| dc.contributor.author | Şentürk, Fevzi | |
| dc.contributor.author | Aras, Cengiz | |
| dc.date.accessioned | 2023-09-20T07:35:03Z | |
| dc.date.available | 2023-09-20T07:35:03Z | |
| dc.date.issued | 2023 | en_US |
| dc.identifier.citation | Kılıçarslan, O., Yılmaz Çebi, A., Uçar, D., Şentürk, F. ve Aras, C. (2023). Bilateral cystoid macular edema after COVID-19: 1 year follow up. Ocular Immunology and Inflammation, 31(6), 1236-1239. https://doi.org/10.1080/09273948.2022.2114916 | en_US |
| dc.identifier.issn | 0927-3948 | |
| dc.identifier.issn | 1744-5078 | |
| dc.identifier.uri | https://doi.org/10.1080/09273948.2022.2114916 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/11465 | |
| dc.description.abstract | Purpose: The aim is to report a case of bilateral macular edema after COVID-19 pneumonia.
Case Report: A 66-year-old male patient with history of COVID-19 pneumonia presented to us with decreased vision. Examination showed bilateral cystoid macular edema (CME), which was confirmed on optical coherence tomography (OCT). There were no findings in the fundus examination. He had no systemic disease, drug or surgery history, or any factors that could explain the clinic presentation. Work-up for uveitis was unremarkable. After topical therapy with brinzolamide 1% and nepafenac 0.1%, macular edema regressed in a month.
Conclusion: This is an unusual case of CME in previous COVID-19 infection. This presentation may be a parainfectious or a post-viral manifestation of COVID-19. | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Taylor and Francis Ltd. | en_US |
| dc.rights | info:eu-repo/semantics/embargoedAccess | en_US |
| dc.subject | COVID-19 | en_US |
| dc.subject | Macular Edema | en_US |
| dc.subject | Optical Coherence Tomography | en_US |
| dc.subject | Parainfectious | en_US |
| dc.title | Bilateral cystoid macular edema after COVID-19: 1 year follow up | en_US |
| dc.type | letter | en_US |
| dc.relation.ispartof | Ocular Immunology and Inflammation | en_US |
| dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Göz Hastalıkları Ana Bilim Dalı | en_US |
| dc.authorid | 0000-0002-8851-6559 | en_US |
| dc.authorid | 0000-0002-8047-5553 | en_US |
| dc.identifier.volume | 31 | en_US |
| dc.identifier.issue | 6 | en_US |
| dc.identifier.startpage | 1236 | en_US |
| dc.identifier.endpage | 1239 | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
| dc.identifier.doi | 10.1080/09273948.2022.2114916 | en_US |
| dc.institutionauthor | Şentürk, Fevzi | |
| dc.institutionauthor | Aras, Cengiz | |
| dc.identifier.wosquality | Q2 | en_US |
| dc.identifier.wos | 000851605500001 | en_US |
| dc.identifier.scopus | 2-s2.0-85138305408 | en_US |
| dc.identifier.pmid | 36074579 | en_US |
| dc.identifier.scopusquality | Q1 | en_US |
